Brief news reports on Tuberculosis

World AIDS Day: Equalize – addressing inequalities to End TB and AIDS!

The World Health Organization is joining partners in commemorating World AIDS Day 2022, and calls on global leaders and citizens to equalize access to essential HIV and TB services, particularly for key and vulnerable populations.

Read More →

Statement by Stop TB Partnership on World AIDS Day 2022

To end HIV/AIDS and TB, we need to ‘equalize’ global commitment, financial resources and attention between the two diseases.

Read More →

Mylab launches first indigenous TB diagnostic kit in India

Pune-based diagnostic kit manufacturer Mylab Discovery Solutions has launched India’s first indigenously developed Tuberculosis detection kit. The PathoDetect kit can also detect multiple drug resistance to Rifampicin and Isoniazid in a single test. TB is one of the biggest killers in India with 4.93 lakh deaths reported in 2020.

Read More →

Vietnam: Scientists team up to eradicate TB

Hanoi (VNS/VNA) - A team of 23 scientists from different hospitals and institutes has conducted a massive scientific research project to help control tuberculosis (TB).

Read More →

TB and COVID-19 lung lesions revealed by high-resolution three-dimensional imaging

Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast, reveals the microscopic anatomy of biological structures. But that magnification comes at a cost — histology shows only two-dimensional shapes because it studies small, flat slices of stained tissue.

Read More →

South Africa’s prisons are a breeding ground for the spread of TB. Our model shows how

South African prisons are famously overcrowded. Prison populations are believed to exceed capacity by an overall 33%, although that number jumps to over 200% at some facilities, according to recent reports.

Read More →

Dr. Fauci reflects on the perpetual challenge of infectious diseases

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in the New England Journal of Medicine. In the piece, Dr. Fauci, who since 1984 has directed the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, reflects on his career responding to infectious disease threats. Dr. Fauci will step down from his positions as NIAID director, chief of NIAID’s Laboratory of Immunoregulation and chief medical advisor to President Joe Biden in December 2022.

Read More →

Opinion: New research and implementing lessons from COVID-19 are key to South Africa’s future TB intervention plans

Our health systems endured a heavy – often invisible – cost during the COVID-19 pandemic. While the country was focused on the battle against this pandemic, long-fought gains against other infectious diseases were being rolled back.

Read More →

In-depth: New resistance tests set to improve TB treatment

Some strains of the TB bacterium have mutated to become resistant to some of the drugs commonly used to treat TB. Accordingly, one of the first questions to ask when someone has TB is which drugs will be effective in fighting that person’s TB. Unfortunately, quick answers to this question are not always available. As a consequence, people are at times treated with drugs that won’t work for their particular strain of TB. What’s worse, these drugs often have significant side effects.

Read More →

Global impact of COVID-19 on childhood TB: an analysis of notification data

A study published in The Lancet Global Health evaluated the impact of COVID-19 on child TB notifications, suggesting that COVID-19 has substantially affected childhood TB services, with the youngest children most affected.

Read More →

Page 1 of 823 · Total posts: 10

1 2 Last→